CoChat

Association Between Use of Statins and Outcomes in Heart Failure With Reduced Ejection Fraction: Prospective Propensity Score Matched Cohort Study of 21 864 Patients in the Swedish Heart Failure Registry

Open access
Alehagen, Urban, Benson, Lina, Edner, Magnus, Dahlström, Ulf, Lund, Lars H. · 2015 · Circulation: Heart Failure
Cited by 49

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background—: In heart failure (HF) with reduced ejection fraction, randomized trials of statins did not demonstrate improved outcomes. However, randomized trials may not always be generalizable. The aim was to determine whether statins are associated with improved outcomes in an unselected nationwide population of patients with HF with reduced ejection fraction overall and in relation to ischemic heart disease (IHD). Methods and Results—: In the Swedish Heart Failure Registry, 21 864 patients with HF with reduced ejection fraction (age ± SD, 72±12 years; 29% women), of whom 10 345 (47%) were treated with statins, were studied. Propensity scores for statin use were derived from 42 baseline variables. The associations between statin use and outcomes were assessed with Cox regressions in a population matched 1:1 based on propensity score and age and in the overall population with adjustment for propensity score and age. The primary outcome was all-cause mortality; secondary outcomes were cardiovascular mortality; HF hospitalization; and combined all-cause mortality or cardiovascular hospitalization. Survival at 1 year in the matched population was 83% for statin-treated versus 79% for untreated patients (hazard ratio, 0.81; 95% confidence interval, 0.76–0.86; P <0.001). In the unmatched population, 1-year survival was 85% for statin-treated versus 79% for untreated patients, hazard ratio after adjustment for propensity score and age was 0.84 (95% confidence interval, 0.80–0.89; P <0.001). No examined baseline variables interacted with statin use except for IHD ( P =0.001), with a hazard ratio of 0.76 (95% confidence interval, 0.70–0.82, P <0.001) with IHD and 0.95 (95% confidence interval, 0.85–1.07; P =0.430 without IHD. Statin use was also associated with reduced risk for all 3 secondary outcomes. Conclusions—: In an unselected nationwide population of patients with HF with reduced ejection fraction, statins were associated with improved outcomes, specifically in the presence of IHD. This contrasts with previous randomized controlled trials. Additional randomized controlled trials with more generalized inclusion or focused on IHD may be warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.114.001730

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 49

Metadata

Authors
Alehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H.
Venue
Circulation: Heart Failure
Published
2015-03
Volume
8
Issue
2
Pages
252-260
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2171461709
Cited by
49
References
7
FWCI
4.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association Between Use of Statins and Outcomes in Heart Failure With Reduced Ejection Fraction: Prospective Propensity Score Matched Cohort Study of 21 864 Patients in the Swedish Heart Failure Registry. https://app.cochat.ai/papers/10.1161/circheartfailure.114.001730
The paper
Alehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H. (2015). Association Between Use of Statins and Outcomes in Heart Failure With Reduced Ejection Fraction: Prospective Propensity Score Matched Cohort Study of 21 864 Patients in the Swedish Heart Failure Registry. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.114.001730

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.